http://www.bing.com:80/search?q=Normalisation+ExampleSearch resultshttp://www.bing.com:80/s/a/rsslogo.gifhttp://www.bing.com:80/search?q=Normalisation+ExampleCopyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.https://www.eirpharmaceuticals.com/Eir Pharmaceuticals is a development stage biotechnology company focused on developing and commercializing health, wellness and pharmaceutical products . The Company’s proprietary biotechnology platform is designed to capture value across multiple markets, with applications for animal health, human consumer, and human health.Sat, 22 Aug 2026 21:12:00 GMThttps://www.eirbiopharma.com/Our therapeutic development efforts center on targeting the Ephrin receptor for the treatment of neurodegenerative disease, proliferative neovascular disease and cancer. Our initial therapeutic focus is the treatment of certain eye diseases by modulation of Ephrin receptor dysregulation.Wed, 26 Aug 2026 02:17:00 GMThttps://pitchbook.com/profiles/company/279906-31Information on valuation, funding, cap tables, investors, and executives for EIR Pharmaceuticals. Use the PitchBook Platform to explore the full profile.Mon, 17 Aug 2026 07:28:00 GMThttps://www.linkedin.com/company/eir-holdings-llcDrugs (re)Discovered. | Eir Pharmaceuticals is a Kansas City based biotechnology startup company focused on developing products for human and animal health.Sat, 28 Jan 2023 21:46:00 GMThttps://www.eirbiopharma.com/aboutEIR Biopharma, Inc. is a preclinical stage biotech company developing therapeutics targeting the Ephrin receptor. Our initial therapeutic development efforts center on targeting the Ephrin receptor for the treatment of eye disease.Mon, 24 Aug 2026 21:39:00 GMThttps://tracxn.com/d/companies/eir-pharmaceuticals/__HScxmHvEEfum3r0MzjsB4Mfswg_9Whx83tPsMCuCklYEIR Pharmaceuticals is a seed company based in Kansas City (United States), founded in 2018 by John Crowe. It operates as a R&D company focused on manufacturing of drugs for multiple therapeutic areas.Fri, 06 Mar 2026 06:03:00 GMThttps://www.dnb.com/business-directory/company-profiles.eir_pharmaceuticals_llc.bebc480d61a5af6fe48bb11dd4c0a03e.htmlFind company research, competitor information, contact details & financial data for EIR PHARMACEUTICALS, LLC of Olathe, Kansas. Get the latest business insights from Dun & Bradstreet.Sun, 19 Apr 2026 09:15:00 GMThttps://www.bizapedia.com/ks/eir-pharmaceuticals-llc.htmlDiscover Company Info on EIR PHARMACEUTICALS, LLC in Kansas City, KS, such as Contacts, Addresses, Reviews, and Registered Agent.Sun, 26 Oct 2025 20:35:00 GMThttps://www.crunchbase.com/organization/eir-pharmaceuticalsEIR Pharmaceuticals is a biotechnology company that focuses on developing and commercializing health, wellness and pharmaceutical products for humans and animals.Mon, 24 Aug 2026 19:16:00 GMThttps://opengovus.com/sam-entity/W6V2TT9RGUL9EIR PHARMACEUTICALS, LLC is an entity operating in Olathe, Kansas registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA).Wed, 21 Dec 2022 04:16:00 GMT